Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-0403 add-on therapy to alpha-glucosidase inhibitor or pioglitazone in type 2 diabetes
jRCT2080220767Phase 3
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing SK-0403 add-on with Placebo add-on (2 arms).
02
Drugs
anagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220767.